CLINICAL FEATURES OF 22Q11.2 DELETION SYNDROME: A LITERATURE REVIEW AND CASE SERIES REPORTS

  • Tatjana Stankovic 1. Faculty of Medicine, University of Niš, Serbia 2. Clinic of Pediatrics, University Clinical Center Niš, Serbia https://orcid.org/0000-0003-0522-2772
  • Katarina Harfman Mihajlović Faculty of Medicine, University of Niš, Serbia
  • Dragana Lazarević 1. Faculty of Medicine, University of Niš, Serbia 2. Clinic of Pediatrics, University Clinical Center Niš, Serbia
  • Karin Vasić 1. Faculty of Medicine, University of Niš, Serbia 2. Clinic of Pediatrics, University Clinical Center Niš, Serbia
  • Hristina Stamenković 1. Faculty of Medicine, University of Niš, Serbia 2. Clinic of Pediatrics, University Clinical Center Niš, Serbia
Keywords: 22q11.2 deletion syndrome, thymus, congenital defect in T cell immunity, hypocalcemia, congenital heart defects

Abstract


The 22q11.2 deletion syndrome is the most common microdeletion syndrome. The clinical features show a broad spectrum of multisystem manifestations and include congenital heart defects, hypoparathyroidism associated with hypocalcemia, hypoplasia of the thymus and subsequent immunodeficiency, distinctive facial features, velopharyngeal insufficiency, and developmental delay or learning disabilities. Retrospective analysis of medical data was conducted and the spectrum of clinical manifestations of case series of five patients with 22q11.2 deletion syndrome is presented. A small series of patients with a 22q11.2 deletion syndrome is described, but still a sufficient number that undisputably displays a recognizable spectrum of manifestations. All patients expressed elements of facial dysmorphism and signs of immune system dysfunction which ranged from lymphopenia and recurrent respiratory infections to congenital defect in T cell immunity. Almost all of the reported patients had associated conotruncal congenital heart defects, and the majority of cases presented with hypocalcemia and elements of motor and developmental delay. Increased awareness of multisystemic features of 22q11.2 deletion syndrome is pivotal for early recognition and early initiation of comprehensive care and treatment.  

References

Boyarchuk O, Volyanska L, Dmytrash L. Clinical variability of chromosome 22q11.2 deletion syndrome. Central European Journal of Immunology 2017; 42(4): 412-417. [CrossRef] [PubMed]

Cortés-Martín J, Penuela NL, Sanchez-Garcia JC, Montiel-Troya M, Díaz-Rodríguez L, Rodríguez-Blanque R. Deletion Syndrome 22q11.2: A Systematic Review. Children 2022; 9(8): 1168. [CrossRef] [PubMed]

Davies EG. Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia. Front Immunol 2013; 4: 322. [CrossRef] [PubMed]

Eryılmaz SK, Baş F, Satan A, Darendeliler F, Bundak R, Günöz H, Saka N. A patient with 22q11.2 deletion syndrome: case report. J Clin Res Pediatr Endocrinol 2009; 1(3): 151-4. [CrossRef] [PubMed]

Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome, the chromosome 22q11.2 deletion syndromes. Lancet 2007; 370(9596): 1443-52. [CrossRef] [PubMed]

Marom T, Roth Y, Goldfarb A, Cinamon U. Head and neck manifestations of 22q11.2 deletion syndromes. Eur Arch Otorhinolaryngol 2012; 269(2): 381-7. [CrossRef] [PubMed]

McDonald-McGinn DM, Hain HS, Emanuel BS, Zackai EH. 22q11.2 Deletion Syndrome. 1999 Sep 23 [Updated 2020 Feb 27]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2024. [CrossRef] [PubMed]

Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 2010; 105(11): 1617-24. [CrossRef] [PubMed]

Óskarsdóttir S, Boot E, Crowley TB, Loo JCY, Arganbright JM, Armando M, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genetics in Medicine 2023; 25(3): 100338. [CrossRef] [PubMed]

Parker H, Conway E, Goldsberry J, Jeffries S, Price E, Oxford JTl. Genetic and molecular aspects of Di George syndrome. Bios 2014; 86(2): 109-17. [CrossRef]

Szczawińska-Popłonyk A, Schwartzmann E, Chmara Z, Krysa T, Majchrzycki M et al. Chromosome 22q11.2 Deletion Syndrome: A Comprehensive Review of Molecular Genetics in the Context of Multidisciplinary Clinical Approach. Int J Mol Sci 2023; 24:8317. [CrossRef] [PubMed]

Tulloh RMR, Medrano-Lopez C, Checchia PA, Stapper C, Sumitomo N, Gorenflo M, et al. CHD and respiratory syncytial virus: global expert exchange recommendations. Cardiology in the Young 2017; 27(8): 1504-21. [CrossRef] [PubMed]

Wójtowicz-Marzec M, Wysokińska B, Wysokiński A. Neonatal manifestation of 22q11.2 deletion syndrome – four case reports and a mini-literature review. Ann Agric Environ Med 2023; 30(4): 773-8. [CrossRef] [PubMed]

Yu S, Graf WD, Shprintzen RJ. Genomic disorders on chromosome 22. Curr Opin Pediatr 2012; 24(6): 665-71. [CrossRef] [PubMed]

Published
2024/10/31
Section
Original article